retatrutide while breastfeeding After Pregnancy: A Guide for Moms in Canada Retatrutide for Women: Safety, Results

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Dose escalation and symptom patterns Each dose increase on a GLP-1 medication can trigger a new round of sulfur burps

These appetite-suppressing treatments can help you manage hunger, support metabolic health, and make lasting progress

doi: 10.1101/751198 62 NamKoongCKimMSJangB-TLeeYHChoY-MChoiHJ

Alzheimers Disease International: London, 2018

For high-risk patients or those with documented decline despite optimal lifestyle measures, referral to clinical trials of emerging anabolic/anti-catabolic therapies is appropriate